N-terphenylpicolinamide derivatives designed to target PD-L1 increase activation and proliferation of T cells, and their cytotoxic properties toward cancer cells

Key Points

• Increased activation and proliferation of T cells indicates improved immune response to cancer.
• N-terphenylpicolinamide derivatives specifically target PD-L1, enhancing anti-tumor effects.
• The study employs a biochemical assay to evaluate cytotoxic properties against cancer cells over several experiments.
• Therapeutic strategies based on these findings may improve cancer treatment efficacy and patient outcomes.